Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life
- PMID: 24527863
- DOI: 10.3171/2014.1.PEDS13532
Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life
Abstract
Object: Reports of myxopapillary ependymomas (MPEs) of the spinal cord in pediatric patients are scarce. In the literature, various authors have shared their experiences with small groups of patients, which makes it difficult to create a consensus regarding the treatment approach for spinal MPEs in young patients. The aim of this study was to perform a survival analysis of patients in the first 2 decades of life whose cases were selected from the published studies, and to examine the influence of various factors on outcomes.
Methods: A comprehensive search of studies published in English was performed on PubMed. Patients whose age was ≤ 20 years were included for integrative analysis. Information about age, treatment characteristics, critical events (progression, recurrence, and death), time to critical events, and follow-up duration was recorded. The degree of association of the various factors with the survival outcome was calculated by using Kaplan-Meier estimator and Cox proportional hazard model techniques.
Results: A total of 95 patients were included in the analysis. The overall rate of recurrence (RR) was 34.7% (n = 33), with a median time to recurrence of 36 months (range 2-100 months). Progression-free survival (PFS) and overall survival rates at 5 years were 73.7% and 98.9%, respectively. Addition of radiotherapy (RT) following resection significantly improved PFS (log-rank test, p = 0.008). In patients who underwent subtotal resection (STR), administering RT (STR + RT) improved outcome with the lowest failure rates (10.3%), superior to patients who underwent gross-total resection (GTR) alone (RR 43.1%; log-rank test, p < 0.001). Addition of RT to patients who underwent GTR was not beneficial (log-rank test, p = 0.628). In patients who had disseminated tumor at presentation, adjuvant RT controlled the disease effectively. High-dose RT (≥ 50 Gy) did not change PFS (log-rank test, p = 0.710).
Conclusions: Routine inclusion of RT in the treatment protocol for spinal MPEs in young patients should be considered. Complete resection is always the goal of tumor resection. However, when complete resection does not seem to be possible in complex lesions, RT should be used as an adjunct to avoid aggressive resection and to minimize inadvertent injury to the surrounding neural tissues. High-dose RT (≥ 50 Gy) did not provide additional survival benefits, although this association needs to be evaluated by prospective studies.
Similar articles
-
Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.Neurosurg Focus. 2015 Aug;39(2):E8. doi: 10.3171/2015.5.FOCUS15164. Neurosurg Focus. 2015. PMID: 26235025
-
Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.Neuro Oncol. 2013 Feb;15(2):208-15. doi: 10.1093/neuonc/nos286. Epub 2012 Dec 9. Neuro Oncol. 2013. PMID: 23229996 Free PMC article.
-
Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.J Neurosurg Pediatr. 2014 Apr;13(4):393-9. doi: 10.3171/2013.12.PEDS13383. Epub 2014 Feb 7. J Neurosurg Pediatr. 2014. PMID: 24506340
-
Outcome predictors in the management of spinal myxopapillary ependymoma: an integrative survival analysis.World Neurosurg. 2015 May;83(5):852-9. doi: 10.1016/j.wneu.2014.08.006. Epub 2014 Aug 7. World Neurosurg. 2015. PMID: 25108296 Review.
-
Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.J Neurosurg. 2016 Aug;125(2):410-8. doi: 10.3171/2015.7.JNS151187. Epub 2016 Jan 8. J Neurosurg. 2016. PMID: 26745489 Review.
Cited by
-
Myxopapillary ependymomas in children: imaging, treatment and outcomes.J Neurooncol. 2016 Jan;126(1):165-174. doi: 10.1007/s11060-015-1955-2. J Neurooncol. 2016. PMID: 26468139
-
Spinal drop metastasis in myxopapillary ependymoma: a case report and a review of treatment options.Rare Tumors. 2014 Jun 16;6(2):5404. doi: 10.4081/rt.2014.5404. eCollection 2014 May 13. Rare Tumors. 2014. PMID: 25002955 Free PMC article.
-
National trends in management of adult myxopapillary ependymomas.J Clin Neurosci. 2020 Mar;73:162-167. doi: 10.1016/j.jocn.2019.12.049. Epub 2020 Jan 24. J Clin Neurosci. 2020. PMID: 31987634 Free PMC article.
-
Biology and management of ependymomas.Neuro Oncol. 2016 Jul;18(7):902-13. doi: 10.1093/neuonc/now016. Epub 2016 Mar 28. Neuro Oncol. 2016. PMID: 27022130 Free PMC article. Review.
-
Clinicopathologic features of anaplastic myxopapillary ependymomas.Brain Pathol. 2019 Jan;29(1):75-84. doi: 10.1111/bpa.12673. Brain Pathol. 2019. PMID: 30417460 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources